Biotech company Factor Bioscience sued rival Cellectis and pharmaceutical giant AstraZeneca in Delaware federal court on Friday for allegedly infringing three patents related to gene-editing technology used in cancer treatments.
AstraZeneca, Cellectis targeted in patent lawsuit over gene-editing technology